T. K. Teksut Et Al. , "Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment," Journal of Clinical Neuroscience , vol.96, pp.229-230, 2022
Teksut, T. K. Et Al. 2022. Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment. Journal of Clinical Neuroscience , vol.96 , 229-230.
Teksut, T. K., Irkec, C., Altiparmak, T., & Fidan, I., (2022). Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment. Journal of Clinical Neuroscience , vol.96, 229-230.
Teksut, Tuba Et Al. "Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment," Journal of Clinical Neuroscience , vol.96, 229-230, 2022
Teksut, Tuba K. Et Al. "Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment." Journal of Clinical Neuroscience , vol.96, pp.229-230, 2022
Teksut, T. K. Et Al. (2022) . "Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment." Journal of Clinical Neuroscience , vol.96, pp.229-230.
@article{article, author={Tuba Kuz Teksut Et Al. }, title={Fractalkine levels in patients with vascular dementia, Alzheimer's disease and mild cognitive impairment}, journal={Journal of Clinical Neuroscience}, year=2022, pages={229-230} }